Reference health
Pricing and Value Creation in Private Equity-backed Buy-and-Build Strategies
43/43 checkable references clean · checked 2026-08-25
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
25 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 43 checked references that resolve
resolves10.1093/rfs/hhy045
Real Effects of the Sovereign Debt Crisis in Europe: Evidence from Syndicated Loans
resolves10.1016/j.rfe.2011.09.001
Value creation and pricing in buyouts: Empirical evidence from Europe and North America
resolves10.1111/jsbm.12235
Opening the Black Box: Power in Buyout Negotiations and the Moderating Role of Private Equity Specialization
resolves10.1016/j.jfineco.2014.08.002
Fund managers under pressure: Rationale and determinants of secondary buyouts
resolves10.1111/jofi.12082
Borrow Cheap, Buy High? The Determinants of Leverage and Pricing in Buyouts
resolves10.1016/j.jfineco.2007.11.005
Why do private acquirers pay so little compared to public acquirers?☆
resolves10.1111/j.1540-6261.1975.tb01018.x
SIZE, LEVERAGE, AND DIVIDEND RECORD AS DETERMINANTS OF EQUITY RISK
resolves10.1093/rof/rfu009
The Effects of Government-Sponsored Venture Capital: International Evidence
resolves10.1016/j.jfineco.2016.01.033
How persistent is private equity performance? Evidence from deal-level data
resolves10.1016/j.bushor.2014.05.006
Equity-worthiness and equity-willingness: Key factors in private equity deals
resolves10.1016/j.jfi.2016.07.001
The importance of size in private equity: Evidence from a survey of limited partners
resolves10.1017/S0022109012000361
It Pays to Follow the Leader: Acquiring Targets Picked by Private Equity
resolves10.1016/j.jcorpfin.2012.06.006
One size does not fit all: Selling firms to private equity versus strategic acquirers
resolves10.1093/rfs/hht021
Identifying the Valuation Effects and Agency Costs of Corporate Diversification: Evidence from the Geographic Diversification of U.S. Banks
resolves10.1016/j.jcorpfin.2017.04.006
Inorganic growth strategies and the evolution of the private equity business model
resolves10.1016/j.jcorpfin.2018.08.016
Divisional buyouts by private equity and the market for divested assets
resolves10.2139/ssrn.4169612
Buying Performance? The Impact of Multiple Arbitrage in B&B Strategies
resolves10.1017/S0022109015000113
Giants at the Gate: Investment Returns and Diseconomies of Scale in Private Equity
resolves10.1016/j.jcorpfin.2007.04.002
The impact of corporate governance mechanisms on value increase in leveraged buyouts
resolves10.1002/smj.2332
Small fish, big fish: The performance effects of the relative standing in partners' affiliate portfolios
resolves10.1016/j.jcorpfin.2007.04.005
Why do public firms go private in the UK? The impact of private equity investors, incentive realignment and undervaluation
resolves10.1111/jbfa.12221
The Effects of the Specialization of Private Equity Firms on their Exit Strategy
resolves10.1016/j.jfineco.2016.09.008
Cyclicality, performance measurement, and cash flow liquidity in private equity
resolves10.1093/rof/rfs051
Your Former Employees Matter: Private Equity Firms and Their Financial Advisors
resolves10.1016/j.jcorpfin.2011.11.004
Do private equity owners increase risk of financial distress and bankruptcy?
resolves10.1016/j.jbankfin.2013.01.042
Drivers of holding period firm-level returns in private equity-backed buyouts
resolves10.1016/j.jcorpfin.2011.11.008
Private equity portfolio company performance during the global recession
The 25 references without a DOI — listed, not checked
no DOI — not checkedref7
no DOI — not checkedref14
no DOI — not checkedref22
no DOI — not checkedPrivate equity and Covid-19
no DOI — not checkedWorking out where the value lies
no DOI — not checkedref37
no DOI — not checkedref40
no DOI — not checkedref47
no DOI — not checkedThe new demography of private equity
no DOI — not checkedref53
no DOI — not checkedWe will now list platform characteristics and ask you to rate the importance of these characteristics for a platform company from 1-7. A score of 1 means very unimportant, a score of 4 means neutral, a score of 7 means very important. 1 2 3 4 5 6 7 Ideal platform characteristics High financial performance
no DOI — not checkedWe will now list add-on characteristics and ask you to rate the importance of these characteristics for an add-on company from 1-7. A score of 1 means very unimportant, a score of 4 means neutral, a score of 7 means very important
no DOI — not checkedref56
no DOI — not checkedref57
no DOI — not checkedref58
no DOI — not checkedref59
no DOI — not checkedref60
no DOI — not checkedref61
no DOI — not checkedref62
no DOI — not checkedref63
no DOI — not checkedref64
no DOI — not checkedref65
no DOI — not checkedref66
no DOI — not checkedref67
no DOI — not checkedref68
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-08-25 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.3244189"><img src="https://citestamp.com/citestamped/10.2139/ssrn.3244189/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.3244189)